D. Citerone

发表

Linear Pharmacokinetic Behavior of Ropinirole during Multiple Dosing in Patients with Parkinson's Disease

J. Hubble, W. Koller, A. Taylor, 2000, Journal of clinical pharmacology.

Albiglutide, a Long Lasting Glucagon-Like Peptide-1 Analog, Protects the Rat Heart against Ischemia/Reperfusion Injury: Evidence for Improving Cardiac Metabolic Efficiency

T. Chendrimada, H. Alsaid, W. Bao, 2011, PloS one.

Application of DBS for the quantitative assessment of a protein biologic using on-card digestion LC-MS/MS or immunoassay.

J. Kehler, M. Szapacs, D. Citerone, 2011, Bioanalysis.

SK&F 110679: comparison of absorption following oral or respiratory administration

D. Wall, Philip L. Smith, F. Drake, 1994 .

The Gyrolab™ immunoassay system: a platform for automated bioanalysis and rapid sample turnaround.

Lee Abberley, Kristy J Fraley, Charles S Hottenstein, 2013, Bioanalysis.

Lack of a Pharmacokinetic Interaction at Steady State Between Ropinirole and L‐Dopa in Patients with Parkinson's Disease

M. Cyronak, S. Vakil, A. López-Gil, 1999, Pharmacotherapy.

Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.

O. Rascol, J. Montastruc, C. Thalamas, 1998, British journal of clinical pharmacology.

Interspecies Pharmacokinetics of a Novel Hematoregulatory Peptide (SK&F 107647) in Rats, Dogs, and Oncologic Patients

David E. Martin, J. Nemunaitis, D. Brocks, 1996, Pharmaceutical Research.

Disposition of ropinirole in animals and man.

A. Taylor, J. Keogh, R. Chenery, 1999, Xenobiotica; the fate of foreign compounds in biological systems.

The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease.

F. Stocchi, A. Taylor, A. López-Gil, 1999, British journal of clinical pharmacology.

Absolute quantification of a therapeutic domain antibody using ultra-performance liquid chromatography-mass spectrometry and immunoassay.

C. Hottenstein, J. Kehler, Matthew E. Szapacs, 2010, Bioanalysis.